Monthly Archives: June 2016

//June

First Global Neuroendocrine Tumor Patient Survey Results

“Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs” – a collaborative effort between the International Neuroendocrine Cancer Alliance (INCA) and [...]

By | 2018-05-07T18:28:13+00:00 June 22nd, 2016|News|Comments Off on First Global Neuroendocrine Tumor Patient Survey Results

CNETS Canada Launches NEW WEBSITE

Over the last several years CNETS Canada has worked hard to continuously improve our website and the information contained in it to ensure that it is highly functional and as [...]

By | 2018-05-07T18:28:13+00:00 June 7th, 2016|News|Comments Off on CNETS Canada Launches NEW WEBSITE

New NET Clinical Trial in Canada – Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

A Prospective Single-Arm, Multi-Centre, Study of the Efficacy and Safety of Lutetium-177 Octreotate (Lu-DOTATATE) Treatment With Individualized Dosimetry in Patients With 68Ga-DOTATATE Identified Somatostatin Receptor Positive Neuroendocrine Tumors Not yet [...]

By | 2018-05-07T18:28:13+00:00 June 5th, 2016|Clinical Trial|Comments Off on New NET Clinical Trial in Canada – Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors